e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Basic science and lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The nuclear expression of the small heat shock protein – alpha B crystalline as a marker for poor prognosis in NSCLC patients
R. Cherneva, O. Georgiev, I. Dimova, D. Borisov, D. Toncheva, M. Stamenova, V. Vlasov, N. Trifonova (Sofia, Bulgaria)
Source:
Annual Congress 2009 - Basic science and lung cancer
Session:
Basic science and lung cancer
Session type:
Oral Presentation
Number:
3072
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Cherneva, O. Georgiev, I. Dimova, D. Borisov, D. Toncheva, M. Stamenova, V. Vlasov, N. Trifonova (Sofia, Bulgaria). The nuclear expression of the small heat shock protein – alpha B crystalline as a marker for poor prognosis in NSCLC patients. Eur Respir J 2009; 34: Suppl. 53, 3072
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Inhibitor of DNA-binding (Id) – 1 and 3 proteins overexpression has impact on prognosis of lung adenocarcinoma
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Heat shock protein (HSP) 72 polymorphism in small cell lung cancer (SCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005
Heat shock protein expression in small cell lung cancer (SCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Hypoxia inducible factor-1 alpha (HIF-1 alpha) expression was correlated with the survival in patients with small cell lung cancer (SCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Nuclear expression of Y-Box binding protein (YB-1) as a negative prognostic marker in non-small cell lung cancer
Source: Annual Congress 2003 - Lung cancer biology
Year: 2003
Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
Source: Eur Respir J 2004; 23: 14-19
Year: 2004
Espression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt1, VEGF-R2-Flk1) in non small cell (NSCLC) and small cell lung carcinomas (SCLC). Correlation with clinical outcome
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
Globo h tumor antigen expression is associated with blood group a1 and negative prognosis in NSCLC
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Carbonic anhydrase 9 expression (CA9e) profile combined with growth patterns (GPs) in non-small cell lung cancer (NSCLC) identifies a group of patients with an extremely poor prognosis
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005
EGFR
and
hTERT
mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Akt induced cytoplasmic mislocalization of p27
kip1
protein and correlated with poor prognosis in lung adenocarcinoma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
EGFR and hTERT expression in high risk COPD patients – clinical application
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Characteristics and prognostic relevance of
p
53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
LATE-BREAKING ABSTRACT: A mRNA signature predicts outcome of patients (pts) with advanced non small cell lung cancer (NSCLC) treated with cisplatin (C) and vinorelbine (V): A ELCWP prospective study
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Expression of Fhit protein in non-small cell lung cancer (NSCLC) and its correlation with Ki-67, a proliferative marker
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002
Increased expression of heat shock protein 70 in COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
The significance of T-box transcription factor 5 and CD44s expression in NSCLC: correlation with prognostic markers.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept